Wenxin Kou

753 total citations
21 papers, 355 citations indexed

About

Wenxin Kou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Wenxin Kou has authored 21 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Wenxin Kou's work include Cardiovascular Disease and Adiposity (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Wenxin Kou is often cited by papers focused on Cardiovascular Disease and Adiposity (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Wenxin Kou collaborates with scholars based in China and United States. Wenxin Kou's co-authors include Wenhui Peng, Jianhui Zhuang, Peipei Luan, Weixia Jian, Hailing Li, Yawei Xu, Yifan Zhao, Xu Xu, Qing Yu and Mark W. Feinberg and has published in prestigious journals such as Nature Communications, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Wenxin Kou

19 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenxin Kou China	10	157	94	87	69	64	21	355
Peipei Luan China	9	193 1.2×	93 1.0×	91 1.0×	40 0.6×	56 0.9×	11	356
Alexis Cutchins United States	7	146 0.9×	134 1.4×	133 1.5×	69 1.0×	114 1.8×	15	433
Zhu Hui Liu China	11	129 0.8×	74 0.8×	110 1.3×	139 2.0×	124 1.9×	17	458
Jessica Smith United Kingdom	10	150 1.0×	79 0.8×	52 0.6×	78 1.1×	40 0.6×	17	341
Ze-Bei Zhang China	8	128 0.8×	125 1.3×	59 0.7×	140 2.0×	90 1.4×	11	399
Hexiang Cheng China	7	269 1.7×	142 1.5×	96 1.1×	117 1.7×	69 1.1×	15	480
Yongqi Feng China	10	129 0.8×	32 0.3×	94 1.1×	102 1.5×	60 0.9×	18	340
Aida Collado Sweden	14	163 1.0×	103 1.1×	114 1.3×	93 1.3×	63 1.0×	31	501
Hillary H. Hegener United States	9	100 0.6×	42 0.4×	92 1.1×	120 1.7×	90 1.4×	10	385

Countries citing papers authored by Wenxin Kou

Since Specialization

Citations

This map shows the geographic impact of Wenxin Kou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxin Kou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxin Kou more than expected).

Fields of papers citing papers by Wenxin Kou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxin Kou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxin Kou. The network helps show where Wenxin Kou may publish in the future.

Co-authorship network of co-authors of Wenxin Kou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxin Kou. A scholar is included among the top collaborators of Wenxin Kou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxin Kou. Wenxin Kou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Liang, Dongyang Jiang, Wenxin Kou, & Yawei Xu. (2025). MicroRNA-130 as a critical modulator of cardiac remodeling: interplay between autophagic flux and ferroptotic pathways in acute myocardial infarction. Molecular and Cellular Probes. 83. 102037–102037.

Liang, Yang, Xiaoying Li, Guo‐Hua Zhong, et al.. (2025). High Transverse Relaxation Microsphere Induced Low K Toughness Polyimide Films. ACS Applied Polymer Materials. 7(9). 5394–5406.

Kou, Wenxin, et al.. (2024). A game theory-based pricing model for ancillary services in electricity markets. Applied Mathematics and Nonlinear Sciences. 9(1). 1 indexed citations

Zhang, Rong, Rui Li, Jian‐Pei Fang, et al.. (2024). Thalassemia caused by complex large fragment rearrangements. QJM. 117(9). 672–674. 1 indexed citations

Kou, Wenxin, Ming Zhai, Yanxi Zeng, et al.. (2023). Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes. Cell & Bioscience. 13(1). 12–12. 6 indexed citations

Yu, Qing, Wenxin Kou, Ming Zhai, et al.. (2023). Macrophage-Specific NLRC5 Protects From Cardiac Remodeling Through Interaction With HSPA8. JACC Basic to Translational Science. 8(5). 479–496. 16 indexed citations

Wang, Bo, Wenxin Kou, Hongwei Ji, et al.. (2022). Prognostic value of plasma adipokine chemerin in patients with coronary artery disease. Frontiers in Cardiovascular Medicine. 9. 968349–968349. 9 indexed citations

Li, Mingjie, Zhijun Lei, Wenxin Kou, et al.. (2022). Self-managed weight loss by smart body fat scales ameliorates obesity-related body composition during the COVID-19 pandemic: A follow-up study in Chinese population. Frontiers in Endocrinology. 13. 996814–996814. 2 indexed citations

Zhai, Ming, Peipei Luan, Wenxin Kou, et al.. (2022). Extracellular traps from activated vascular smooth muscle cells drive the progression of atherosclerosis. Nature Communications. 13(1). 7500–7500. 40 indexed citations

10.

Kou, Wenxin, et al.. (2022). High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis. BMC Cancer. 22(1). 110–110. 19 indexed citations

11.

Zhang, Jingying, Kai Tang, Wenxin Kou, et al.. (2021). Decreased plasma musclin levels are associated with potential atrial fibrillation in non-diabetic patients. Annals of Translational Medicine. 9(3). 203–203. 2 indexed citations

12.

Xu, Xu, Peipei Luan, Wenxin Kou, et al.. (2021). The subcellular redistribution of NLRC5 promotes angiogenesis via interacting with STAT3 in endothelial cells. Theranostics. 11(9). 4483–4501. 13 indexed citations

13.

Li, Bo, You Wu, Bingyu Li, et al.. (2021). The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease. Frontiers in Cardiovascular Medicine. 8. 756889–756889. 21 indexed citations

14.

Kou, Wenxin, Peipei Luan, Weixia Jian, et al.. (2020). Plasma vaspin is an effective biomarker for evaluation of future cardiovascular events in patients with chest pain: a 5-year retrospective observational study. Annals of Translational Medicine. 8(7). 479–479. 7 indexed citations

15.

Tang, Kai, Hailing Li, Dongdong Zhao, et al.. (2019). Rs4968309 in Myosin Light Chain 4 (<i>MYL4</i>) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease. Circulation Journal. 83(10). 1994–2001. 9 indexed citations

16.

Luan, Peipei, Weixia Jian, Xu Xu, et al.. (2019). NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ. Nature Communications. 10(1). 33 indexed citations

17.

Yu, Qing, Wenxin Kou, Xu Xu, et al.. (2019). FNDC5/Irisin inhibits pathological cardiac hypertrophy. Clinical Science. 133(5). 611–627. 87 indexed citations

18.

Kou, Wenxin, Xu Xu, Mengyao Chen, et al.. (2018). The inhibition of the effect and mechanism of vascular intimal hyperplasia in Tiam1 knockout mice. Biochemical and Biophysical Research Communications. 497(1). 248–255. 3 indexed citations

19.

Zhang, Xianlin, Hailing Li, Wenxin Kou, et al.. (2018). Increased plasma microfibrillar-associated protein 4 is associated with atrial fibrillation and more advanced left atrial remodelling. Archives of Medical Science. 15(3). 632–640. 15 indexed citations

20.

Luan, Peipei, Jianhui Zhuang, Jun Zou, et al.. (2017). NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation. The FASEB Journal. 32(2). 1070–1084. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact